EP Patent

EP0381181A2 — A system for the controlled release of active agents and a process for its preparation

Assigned to IPA INTERNATIONALE PHARMA AGENTUR GmbH · Expires 1990-08-08 · 36y expired

What this patent protects

The invention relates to a system for the controlled release of active agents and a process for its preparation, pref­erably an orally administrable pharmaceutical preparation for various, especially soluble, pharmaceutical agents, hav­ing even, controlled active agent release es…

USPTO Abstract

The invention relates to a system for the controlled release of active agents and a process for its preparation, pref­erably an orally administrable pharmaceutical preparation for various, especially soluble, pharmaceutical agents, hav­ing even, controlled active agent release essentially caused by convective processes. The system of the invention is similar in therapeutic effec­tivity to an intravenous drip, i.e. the even and complete release of the active agent from the pharmaceutical prepara­tion for a physiologically and therapeutically practical period of time caused by essentially convective processes. This leads to a constant therapeutic blood level which gua­rantees the long-term effect of the drug whilst reducing the adverse effects and improving local tolerance in the gas­trointestinal tract at the same time. Furthermore, with the composition according to the invention of the pharmaceutical preparation and the preparation pro­cess according to the invention, damages to the shell con­trolling the release of the pharmaceutical agent will not lead to dose-dumping, as is usually the case in membrane-­controlled pharmaceutical agent release, and the preset re­lease rate will be reached within a short period of time.

Drugs covered by this patent

Patent Metadata

Patent number
EP0381181A2
Jurisdiction
EP
Classification
Expires
1990-08-08
Drug substance claim
No
Drug product claim
No
Assignee
IPA INTERNATIONALE PHARMA AGENTUR GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.